US CDC recommends older Americans should get another COVID shot this spring
Reuters
Published Feb 28, 2024 04:36PM ET
Updated Feb 28, 2024 06:07PM ET
(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) director on Wednesday signed off on the use of updated COVID vaccines as a second annual shot for adults aged 65 and older.
The final recommendation from director Mandy Cohen comes after an expert advisory group to the CDC on Wednesday said U.S. adults aged 65 and older should get a second annual COVID-19 shot this spring, strengthening their recommendations from last year.
The CDC's Advisory Committee For Immunization Practices (ACIP) voted 11-1 to say that older Americans should get another shot this spring, according to the agency.
Last year, the committee only recommended an optional additional dose for the age group.
"Most COVID-19 deaths and hospitalizations last year were among people 65 years and older. An additional vaccine dose can provide added protection that may have decreased over time for those at highest risk," said Cohen.
Adults aged 65 years and older are disproportionately impacted by COVID-19, with more than half of COVID-19 hospitalizations during October 2023 to December 2023 occurring in this age group, the CDC said.
According to CDC estimates, around 22% of adults in the United States have received the COVID vaccine that was updated for the 2023-24 vaccination season, including close to 42% of those aged 65 or older.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.